Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJulie R. Brahmer, John A. Thompson, Kelly Brassil et al.|Journal of Clinical Oncology|2018Cited by 3.7k
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitisKarthik Suresh, Franco R. D’Alessio, Jarushka Naidoo et al.|Journal of Clinical Investigation|2019Cited by 198